Anna Dąbrowska-Iwanicka

Anna Dąbrowska-Iwanicka

Center of Oncology Institute Polish Academy of Sciences - Warsaw / Poland
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4482327
Center of Oncology Institute Polska Akademia Nauk
person_outline Anna Dąbrowska-Iwanicka's MOST POPULAR ARTICLES
1-) Statins impair antitumor effects of rituximab by inducing conformational changes of CD20 M Winiarska, J Bil, E Wilczek, GM Wilczynski, M Lekka, PJ Engelberts, ... PLoS medicine 5 (3), e64, 2008 1532008
2-) Cardiotoxicity of the anticancer therapeutic agent bortezomib D Nowis, M Mączewski, U Mackiewicz, M Kujawa, A Ratajska, ... The American journal of pathology 176 (6), 2658-2668, 2010 1412010
3-) Primary mediastinal large B-cell lymphomaA Dabrowska-Iwanicka, JA WalewskiCurrent hematologic malignancy reports 9 (3), 273-283, 2014602014
4-) Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicityJ Bil, M Winiarska, D Nowis, K Bojarczuk, A Dabrowska-Iwanicka, ...Blood, The Journal of the American Society of Hematology 115 (18), 3745-3755, 2010612010
5-) Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice.WS Golab J, Stoklosa T, Czajka A, Dabrowska A, Jakobisiak M, Zagozdzon R ...Anticancer Res. 2000 May-Jun;20(3A):1717-21, 200051*2000